NSE: RALLIS | BSE: 500355

Strong Performer, Getting Expensive

Download real time

355.00 11.45 (3.33%)

High volume today

NSE 14 Jul, 2025 2:37 PM (IST)

6,903.6

Market Cap

Below industry Median

Beta 1Year

Average volatility

Board Meeting

The board meeting for Rallis India Ltd. is scheduled for today, for the purpose of Quarterly Results See details

Rallis India Ltd. share price target and research reports

Name: Latest research reports of Rallis India Ltd. authored by Prabhudas Lilladhar and published by - Trendlyne research reports.
Item: Rallis India Ltd.
Rating: 3
Author: Prabhudas Lilladhar

Latest analyst research reports with target prices and PDF download for RALLIS, BSE:500355 Rallis India Ltd.

Rallis India Ltd.

20 Jan 2022

355.00

3.33%

Q3FY22 Result Update - Better revenue growth offset by cost headwinds - Downgrade to 'HOLD'

Hold: Rallis India Ltd.

Recommendation Target

Prabhudas Lilladhar

Domestic business up 9% YoY largely from price led growth. Rallis India's (RALI) 3QFY22 results were broadly in line with ours as well as consensus estimates. Key highlights are: 1) domestic revenue grew 9% YoY largely from price-led growth (9MFY22 +12% YoY); while crop care segment was up 13% YoY (9MFY22 +12% YoY); 2) export revenue surged 19% YoY...

Rallis India Ltd. has gained 27.90% in the last 6 Months

Rallis India Ltd.

21 Oct 2021

355.00

3.33%

Rallis India

Hold: Rallis India Ltd.

Recommendation Target

ICICI Securities Limited

Rallis India Ltd. has gained 27.90% in the last 6 Months

Rallis India Ltd.

23 Jul 2021

355.00

3.33%

Rallis India

Buy: Rallis India Ltd.

Target

ICICI Securities Limited

Rallis India Ltd. is trading at high day volume of 4.2M.

Rallis India Ltd.

24 Apr 2021

355.00

3.33%

Rallis India

Buy: Rallis India Ltd.

ICICI Securities Limited

Upcoming capex likely to aid revenue ahead Out of the earmarked capex of | 800 crore over the next five to six years, the company has been initially incurring crop formulation capex to the tune of | 98 crore and MPP plant at Dahej with total cost of | 105 crore. Both of these plants are expected to get commissioned by H2FY22. Since it has historically managed asset turn of 2.25-2.5x, we expect the same to sustain, going ahead. Thus, this bodes well for future growth outlook. Apart from this, it has also been working on backward integration, which should boost gross...

Rallis India Ltd. is trading above all available SMAs

Rallis India Ltd.

23 Apr 2021

355.00

3.33%

Q4FY21 Result Update - Margins to bottom out in a quarter - BUY

Buy: Rallis India Ltd.

Recommendation Target

Prabhudas Lilladhar

RALI's 4QFY21 result outperformance vis--vis our estimates was driven by higher than anticipated international business revenue (up 73% YoY). Deteriorating sales mix in favour of Metribuzin led to 210bps contraction in blended gross margins @ 41.4% (PLe 43%). Ex off-Metribuzin, international business is on a firm footing with volume growth in all molecules. Domestic business performance is also on expected lines with 14% revenue growth. We expect margin pressure to peak out in a quarter or so, as low Metribuzin...

Rallis India Ltd. has gained 27.90% in the last 6 Months

Rallis India Ltd.

20 Jan 2021

355.00

3.33%

Rallis India

Buy: Rallis India Ltd.

Recommendation Target

ICICI Securities Limited

Upcoming capex likely to aid revenue ahead Out of the earmarked capex of | 800 crore over the next 5/6 years, the company has been initially incurring crop formulation capex to the tune of | 110 crore and MPP plant at Dahej with total cost of | 130 crore. Both of these plants are expected to get commissioned by H2FY22. Since it has historically managed asset turn of 2.25-2.5x, we expect the same should likely to sustain in the coming time and thus bodes well for future growth outlook. Apart from this, it has also been doing backward integration, which should likely...

Number of FII/FPI investors decreased from 145 to 132 in Mar 2025 qtr

Rallis India Ltd.

04 Dec 2020

355.00

3.33%

Management Meet Update - Reiterating commitment towards growth - HOLD

Hold: Rallis India Ltd.

Prabhudas Lilladhar

In our recent interaction with management of RALI, they reiterated their Change in Estimates | Target | Reco strategy of both, capacity & portfolio expansion driven growth. Capacity is being enhanced in both domestic (formulation) and international (MPP,...

Number of FII/FPI investors decreased from 145 to 132 in Mar 2025 qtr

Rallis India Ltd.

23 Oct 2020

355.00

3.33%

Rallis India

Sell: Rallis India Ltd.

Target

Dolat Capital

Rallis' 2QFY21 earnings print was below our estimates by 7.1% on sales and 21.2% on EBITDA. Sales/EBITDA/PAT stood at Rs 7.25bn/1.17bn/830mn down by 3.2/1.6/3.3% YoY. We had anticipated fall in sales of international business, however the reported fall was even steeper (down 29% YoY to Rs 1.54bn) than our expectations. Domestic business did report a decent growth by...

Rallis India Ltd. is trading above all available SMAs

Rallis India Ltd.

20 Oct 2020

355.00

3.33%

Q2FY21 Result Update - Pain in Int'l business to persist in short term - Downgrade to 'HOLD'

Hold: Rallis India Ltd.

Target

Prabhudas Lilladhar

Number of FII/FPI investors decreased from 145 to 132 in Mar 2025 qtr

Rallis India Ltd.

24 Jul 2020

355.00

3.33%

Rallis India

Sell: Rallis India Ltd.

Dolat Capital

Rallis grew its consolidated sales by a 6.3% YoY to Rs 6.62bn (D.est: Rs 6.73bn). Controlled other expenses (up 0.7% YoY to Rs 492mn) and employee costs (down 4.7% YoY to Rs 857mn) helped in deriving operating leverage, also a richer product mix supported healthy gross margin expansion of 230 bps YoY to 39.7%. Thus, growth in EBITDA (D.est: Rs 990mn) and PAT (D.est: Rs 705mn) of 35.4% YoY and 52.1% YoY to Rs 1.28bn and Rs 919mn came ahead of our estimates. Within the crop care segment (ex-seeds), domestic business grew by...

Rallis India Ltd. is trading at high day volume of 4.2M.

Is Rallis India Ltd. worth buying?

262 Votes:

Buy 75.19%

Sell 14.5%

Hold 10.31%